The Medicines Company to Participate in the Leerink Partners 7th Annual Global Healthcare Conference

8 Feb 2018

PARSIPPANY, N.J.--(BUSINESS WIRE)--Feb. 8, 2018-- The Medicines Company (NASDAQ:MDCO) today announced that it will participate in the Leerink Partners 7th Annual Global Healthcare Conference on Wednesday, February 14, 2018, in New York City. Clive Meanwell, M.D., Ph.D., Chief Executive Officer, will participate in a fireside chat at 9:00 a.m., Eastern Time.

A live audio webcast will be available in the “Investors-Events/Presentations” section of website. A replay of the fireside chat will be available for approximately 90 days.

About The Medicines Company

The Medicines Company is a biopharmaceutical company driven by an overriding purpose – to save lives, alleviate suffering and contribute to the economics of healthcare. The Company’s goal is to create transformational solutions to address the most pressing healthcare needs facing patients, physicians and providers in cardiovascular care. The Company is headquartered in Parsippany, New Jersey.

Source: The Medicines Company

The Medicines Company
Meg Langan, (973) 290-6319
Vice President
[email protected]
Investor Relations
Krishna Gorti, M.D., (973) 290-6122
Vice President, Investor Relations
[email protected]